Integrated Diagnostics Holdings PLC
LSE:IDHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jindal Stainless Ltd
BSE:532508
|
IN |
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| JE |
|
Integrated Diagnostics Holdings PLC
LSE:IDHC
|
361m USD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
100.8B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
69.6B EUR |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
71.5B USD |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
25.2B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.7B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.4B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.1B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.3B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
10.3B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD |
Loading...
|
Market Distribution
| Min | -49.3% |
| 30th Percentile | -0.8% |
| Median | -0.3% |
| 70th Percentile | 0.1% |
| Max | 830.3% |
Other Profitability Ratios
Integrated Diagnostics Holdings PLC
Glance View
Integrated Diagnostics Holdings Plc engages in the provision of diagnostics services including pathology and molecular diagnostics, genetics testing and basic radiology to patients and other laboratories. The firm operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology and radiology. Its brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Echo-Lab (Nigeria). The company operates in approximately 507 branches. IDH offers 2,000 diagnostic pathology tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy, and substance abuse. Through Al Borg Scan, it offers a range of radiology services, including but not limited to magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, x-ray, mammograms, cath lab facilities, and positron emission tomography-computed tomography (PET-CT).
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Integrated Diagnostics Holdings PLC is 17.6%, which is above its 3-year median of 14.9%.
Over the last 3 years, Integrated Diagnostics Holdings PLC’s Net Margin has decreased from 24.3% to 17.6%. During this period, it reached a low of 9.7% on Jun 30, 2023 and a high of 24.3% on Jun 30, 2022.
